Exelixis Shares Fall After Guggenheim Downgrade

MT Newswires Live
Nov 04

Exelixis (EXEL) shares fell 3.4% in Monday afternoon trading after Guggenheim downgraded the oncology company's stock to neutral from buy.

Trading volume was about 3.04 million shares, compared with the daily average of over 2.63 million.

Price: 37.34, Change: -1.33, Percent Change: -3.44

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10